Skip to content

Blunt Cosponsors Bill to Improve Childhood Cancer Research and Treatment

March 23, 2017

WASHINGTON – U.S. Senator Roy Blunt (Mo.), chairman of the Senate Labor, Health and Human Services, Education and Related Agencies Appropriations Subcommittee, this week cosponsored the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act. The STAR Act is a bipartisan, comprehensive bill that would expand opportunities for childhood cancer research, improve efforts to identify and track incidence of childhood cancer, and enhance the quality of life for childhood cancer survivors.

“A child is diagnosed with cancer every three minutes, and one out of every eight who are diagnosed will lose their life to the disease,” Blunt said. “And, more than half of pediatric cancer patients who do survive will suffer from secondary cancers and other long-term medical issues. The STAR Act will expand pediatric cancer research and help improve the quality of life for childhood cancer survivors.”

As chairman of the Labor/HHS appropriations subcommittee, Blunt secured a $2 billion increase for the National Institutes of Health in the FY 2016 omnibus appropriations bill, which included a five percent increase for the National Cancer Institute. The bill also included $12.6 million in dedicated funding for pediatric medical research, which was authorized under the Gabriella Miller Kids First Act.

Blunt continued, “I’ve been proud to back funding increases for the National Cancer Institute and focus resources towards pediatric oncology research and clinical trials, as well as research to determine the needs, outcomes, and barriers faced by pediatric cancer survivors. I will continue working to prioritize resources for groundbreaking medical research that paves the way for new treatments and cures.”

Read more about the STAR Act here.

Next Article » « Previous Article